These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 24150795)
1. 5α-reductase type 3 enzyme in benign and malignant prostate. Titus MA; Li Y; Kozyreva OG; Maher V; Godoy A; Smith GJ; Mohler JL Prostate; 2014 Feb; 74(3):235-49. PubMed ID: 24150795 [TBL] [Abstract][Full Text] [Related]
2. 5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression. Godoy A; Kawinski E; Li Y; Oka D; Alexiev B; Azzouni F; Titus MA; Mohler JL Prostate; 2011 Jul; 71(10):1033-46. PubMed ID: 21557268 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. Gupta S; Wang Y; Ramos-Garcia R; Shevrin D; Nelson JB; Wang Z Prostate; 2010 Oct; 70(14):1575-85. PubMed ID: 20564326 [TBL] [Abstract][Full Text] [Related]
4. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Bartsch G; Rittmaster RS; Klocker H World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710 [TBL] [Abstract][Full Text] [Related]
5. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3. Negri-Cesi P; Colciago A; Poletti A; Motta M Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295 [TBL] [Abstract][Full Text] [Related]
6. Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention. Li J; Ding Z; Wang Z; Lu JF; Maity SN; Navone NM; Logothetis CJ; Mills GB; Kim J PLoS One; 2011; 6(12):e28840. PubMed ID: 22194926 [TBL] [Abstract][Full Text] [Related]
7. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells. Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J J Androl; 2003; 24(5):681-7. PubMed ID: 12954658 [TBL] [Abstract][Full Text] [Related]
8. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line. Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094 [TBL] [Abstract][Full Text] [Related]
9. The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer. Tindall DJ; Rittmaster RS J Urol; 2008 Apr; 179(4):1235-42. PubMed ID: 18280514 [TBL] [Abstract][Full Text] [Related]
10. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539 [TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Bartsch G; Rittmaster RS; Klocker H Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors. Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697 [TBL] [Abstract][Full Text] [Related]
16. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325 [TBL] [Abstract][Full Text] [Related]
17. Dutasteride affects progesterone metabolizing enzyme activity/expression in human breast cell lines resulting in suppression of cell proliferation and detachment. Wiebe JP; Souter L; Zhang G J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):129-40. PubMed ID: 16806904 [TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis. Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750 [TBL] [Abstract][Full Text] [Related]
19. Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues. Fouad Mansour M; Pelletier M; Tchernof A J Steroid Biochem Mol Biol; 2016 Jul; 161():45-53. PubMed ID: 26855069 [TBL] [Abstract][Full Text] [Related]